John Pappadakis
Chief Commercial Officer
For over 34 years, John Pappadakis has held various sales and marketing leadership roles within the pharma industry to drive commercial excellence. In his current role as Chief Commercial Officer, he is further diversifying Clinical ink’s customer base with the addition of new biopharmaceutical companies while solidifying contract research organization (CRO) relationships and other industry alliances. John will continue to drive Clinical ink’s commercial, marketing, and scientific strategies globally.
Before joining Clinical ink in 2021, John held sales leadership roles at Oracle and IMS Health, where he had responsibilities for both commercial and R&D strategies. He also played an instrumental role in assuring the launch and overall market success of over 30 drug compounds while working at Pfizer and Parke-Davis.
